Literature DB >> 35592202

Rare Case of Osseus Metaplasia in a Detached Remnant Leiomyoma Following Hysteroscopic Myomectomy.

Maha Al Jumaily1, Emad Mikhail1.   

Abstract

Uterine leiomyoma is the most common benign tumor of the uterus, affecting reproductive-age women. Although women with uterine fibroids are commonly asymptomatic, in symptomatic patients, hysteroscopic myomectomy is considered the first-line surgical treatment for intracavitary fibroids in women who wish to maintain fertility.  Osseous metaplasia in uterine fibroids is the transformation of fibroids cells into pure mature or immature bone. It is rare, and few case reports present with osseous metaplasia in uterine fibroids. This is the first report in the literature of osseous metaplasia in a remnant fibroid after hysteroscopic myomectomy. Every effort should be attempted to ensure complete retrieval of the detached fibroid remnant after hysteroscopic resection, as this might decrease the risk for subsequent surgeries.
Copyright © 2022, Al Jumaily et al.

Entities:  

Keywords:  gyn pathology; hysteroscopic polypectomy/myomectomy; leiomyoma; myoma uteri; myomectomy; ob-gyn; osseus metaplasia; uterine leiomyoma

Year:  2022        PMID: 35592202      PMCID: PMC9110041          DOI: 10.7759/cureus.24156

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  13 in total

1.  AAGL practice report: practice guidelines for the diagnosis and management of submucous leiomyomas.

Authors: 
Journal:  J Minim Invasive Gynecol       Date:  2012 Mar-Apr       Impact factor: 4.137

2.  Long-term results of hysteroscopic myomectomy for abnormal uterine bleeding.

Authors:  M H Emanuel; K Wamsteker; A A Hart; G Metz; F B Lammes
Journal:  Obstet Gynecol       Date:  1999-05       Impact factor: 7.661

3.  The management of uterine leiomyomas.

Authors:  George A Vilos; Catherine Allaire; Philippe-Yves Laberge; Nicholas Leyland
Journal:  J Obstet Gynaecol Can       Date:  2015-02

Review 4.  Management of uterine fibroids in the patient pursuing assisted reproductive technologies.

Authors:  Mohammad Ezzati; John M Norian; James H Segars
Journal:  Womens Health (Lond)       Date:  2009-07

5.  Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma.

Authors:  William H Catherino; Heba M Eltoukhi; Ayman Al-Hendy
Journal:  Semin Reprod Med       Date:  2013-08-09       Impact factor: 1.303

6.  Osseous metaplasia in leiomyoma: A first in a uterine leiomyoma.

Authors:  Bal Chander; Shashank Shekhar
Journal:  J Cancer Res Ther       Date:  2015 Jul-Sep       Impact factor: 1.805

7.  Epidemiology of uterine fibroids: a systematic review.

Authors:  E A Stewart; C L Cookson; R A Gandolfo; R Schulze-Rath
Journal:  BJOG       Date:  2017-05-13       Impact factor: 6.531

Review 8.  Current medical treatment of uterine fibroids.

Authors:  Geum Seon Sohn; SiHyun Cho; Yong Man Kim; Chi-Heum Cho; Mee-Ran Kim; Sa Ra Lee
Journal:  Obstet Gynecol Sci       Date:  2018-02-13

Review 9.  Etiology and pathogenesis of uterine leiomyomas: a review.

Authors:  Gordon P Flake; Janet Andersen; Darlene Dixon
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

Review 10.  Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction.

Authors:  Andrea Ciavattini; Jacopo Di Giuseppe; Piergiorgio Stortoni; Nina Montik; Stefano R Giannubilo; Pietro Litta; Md Soriful Islam; Andrea L Tranquilli; Fernando M Reis; Pasquapina Ciarmela
Journal:  Obstet Gynecol Int       Date:  2013-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.